The Treasury and the Internal Revenue Service have rescinded pandemic-era guidance that allowed high-deductible health plans to cover COVID costs.
Processing Content
The IRS said, in Notice 2023-37, that for plan years starting in 2025 an HDHP will not be permitted to provide health benefits associated with testing for and treatment of COVID-19 without a deductible, or with a deductible below the minimum deductible (for self-only or family coverage) for an HDHP.
This rescinds guidance from three years ago that said HDHPs could pay for coronavirus-related testing and treatment without jeopardizing status because they covered Covid testing or treatment before plan deductibles were met. That guidance now applies only to plan years ending on or before Dec. 31, 2024.
The preventive care safe harbor also does not include screening (i.e., testing) for COVID-19 effective as of the date of publication of the notice, which will appear in the Internal Revenue Bulletin of July 24.
A medical worker administers a COVID-19 test at a testing site in Berkeley, California.
A majority of accounting firms say they are changing their messaging around pricing as clients increasingly question their cost models in the age of AI efficiencies.
The Internal Revenue Service's efforts to leverage artificial intelligence are running into obstacles thanks to the severe cuts in staffing and budgets.
CPAs dealing with the new 1099-DA rules this year are challenged by the fact that they only report gross proceeds this year, leaving them and their clients to calculate cost basis themselves.